Quintrio
Home

Stock overview

Crescent Capital BDC, Inc. Common stock

CCAP

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Last trade $9.90
Day change -$0.185 (-1.84%)
Day range $9.86 – $10.09
Volume 99,882
Market cap $371M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$371.41M
Price / earnings
—
Price / book
0.57×
Price / sales
4.07×
EV / sales
14.15×
EV / EBITDA
-971.52×

Profitability

Earnings per share
-$0.09
Return on assets
-0.2%
Return on equity
-0.48%
Dividend yield
17.54%

Liquidity and leverage

Debt / equity
1.42×
Current ratio
129.68×
Quick ratio
129.68×
Cash ratio
1.26×

Cash flow

Price / cash flow
9.41×
Price / free cash flow
9.41×
Free cash flow
$39.47M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CCAP, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$19.98M$6.91M$32.82M$31.53M$41.12M$29.41M$35.94M$3.6B
Cost of revenue$14.86M$13.74M$13.78M$13.88M$15.15M$14.64M$15.12M$1.77B
Gross profit$5.12M-$6.84M$19.05M$17.65M$25.97M$14.78M$20.81M$1.84B
Selling, general and administrative$4.74M$5.65M$5.86M$5.83M$6.15M$5.94M$5.79M$810M
Research and development————————
Total operating expenses$7.86M$8.13M$10.06M$10.27M$10.55M$10.37M$10.72M$3.23B
Operating income-$2.74M-$14.96M$8.99M$7.38M$15.41M$4.41M$10.09M$369M
Interest expense———————-$56M
Income before taxes-$2.74M-$14.96M$8.99M$7.38M$15.41M$4.41M$10.09M$313M
Income taxes$506K$552K$500K$281K$400K$501K$100K$44M
Net income-$3.25M-$15.51M$8.49M$7.1M$15.01M$3.9M$9.99M$271M
Net income attributable to common shareholders-$3.25M-$15.51M$8.49M$7.1M$15.01M$3.9M$9.99M$266M
EBITDA-$2.74M-$14.96M$8.99M$7.38M$15.41M$4.41M$10.09M$558M
Basic earnings per share-$0.09-$0.42$0.23$0.19$0.41$0.11$0.27$0.98
Diluted earnings per share-$0.09-$0.42$0.23$0.19$0.41$0.11$0.27$0.97

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
The Motley Fool

Crescent Capital: 3 Key Takeaways for Long-Term Investors

Crescent Capital announced a $50 million share repurchase program and a $150 million joint venture to reduce leverage amid a slowdown in direct lending for buyouts, which fell 60% year-over-year. The firm is offsetting subdued buyout activity by increasing add-on financings to existing portfolio companies, which now represent 50% of deal count. Management believes the stock is undervalued relative to net asset value.

Zacks Investment Research

Wall Street Analysts Believe Crescent Capital BDC (CCAP) Could Rally 34.31%: Here's is How to Trade

Crescent Capital BDC (CCAP) has a mean analyst price target of $12.41, suggesting 34.3% upside potential from its current $9.24 price. The stock holds a Zacks Rank #2 (Buy) rating, supported by positive earnings estimate revisions. However, the article cautions that price targets alone should not drive investment decisions, as analysts often set overly optimistic targets due to business incentives.

Zacks Investment Research

Crescent Capital BDC (CCAP) Surpasses Q3 Earnings and Revenue Estimates

Crescent Capital BDC reported Q3 2026 earnings of $0.37 per share, beating consensus estimates of $0.35, with a 5.71% earnings surprise. Revenue of $36.89 million also exceeded expectations by 2.35%, though both metrics declined year-over-year. The stock has underperformed significantly, down 33.2% year-to-date versus the S&P 500's 7.8% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions.

Zacks Investment Research

FS KKR Capital (FSK) Q3 Earnings and Revenues Beat Estimates

FS KKR Capital reported Q3 2026 earnings of $0.46 per share, beating consensus estimates of $0.40, but revenues declined year-over-year to $294 million. The stock has underperformed the S&P 500 by 34.9 percentage points this year, though it maintains a Zacks Rank #2 (Buy) rating based on favorable estimate revisions. The Financial - SBIC & Commercial Industry ranks in the top 28% of industries.

Zacks Investment Research

Are Options Traders Betting on a Big Move in Crescent Capital BDC Stock?

Options traders are pricing in significant volatility for Crescent Capital BDC (CCAP), with the December 18, 2026 $10.00 Put showing high implied volatility. However, the company holds a Zacks Rank #3 (Hold) rating, and analyst estimates for the current quarter have declined from 38 cents to 35 cents per share over the last 60 days, suggesting mixed fundamental outlook.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily
Declared upcoming dividend $0.03 per share
Declared
May 13, 2026
Ex-dividend
Nov 30, 2026
Pay date
Dec 15, 2026
Ex-dividendAmount / sharePay dateType
Sep 30, 2026$0.34Oct 15, 2026recurring
Aug 31, 2026$0.03Sep 15, 2026special
Jun 30, 2026$0.34Jul 15, 2026recurring
May 29, 2026$0.03Jun 15, 2026special
Mar 31, 2026$0.42Apr 15, 2026recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.